MCF Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.44M Buy
25,362
+933
+4% +$217K 0.23% 60
2026
Q1
$5.97M Buy
24,429
+5,460
+29% +$1.27M 0.26% 55
2025
Q4
$3.93M Buy
18,969
+3,309
+21% +$654K 0.22% 52
2025
Q3
$2.9M Buy
15,660
+1,209
+8% +$207K 0.18% 48
2025
Q2
$2.21M Buy
14,451
+80
+0.6% +$12.3K 0.15% 53
2025
Q1
$2.38M Sell
14,371
-629
-4% -$98.4K 0.17% 47
2024
Q4
$2.17M Buy
15,000
+852
+6% +$132K 0.15% 51
2024
Q3
$2.29M Sell
14,148
-123
-0.9% -$19.6K 0.16% 51
2024
Q2
$2.09M Buy
14,271
+90
+0.6% +$13.4K 0.16% 52
2024
Q1
$2.24M Sell
14,181
-1,587
-10% -$253K 0.17% 48
2023
Q4
$2.47M Buy
15,768
+2,830
+22% +$434K 0.2% 44
2023
Q3
$2.02M Buy
12,938
+1,707
+15% +$282K 0.18% 49
2023
Q2
$1.86M Sell
11,231
-95
-0.8% -$15.3K 0.17% 43
2023
Q1
$1.76M Sell
11,326
-299
-3% -$48.3K 0.16% 44
2022
Q4
$2.05M Sell
11,625
-126
-1% -$21.8K 0.21% 37
2022
Q3
$1.92M Buy
11,751
+377
+3% +$63.8K 0.21% 38
2022
Q2
$2.02M Buy
11,374
+389
+4% +$69.3K 0.21% 34
2022
Q1
$1.95M Buy
+10,985
New +$1.87M 0.18% 34
2021
Q4
Sell
-11,382
Closed -$1.84M 380
2021
Q3
$1.84M Buy
11,382
+1,190
+12% +$203K 0.19% 38
2021
Q2
$1.68M Buy
10,192
+21
+0.2% +$3.48K 0.17% 39
2021
Q1
$1.67M Buy
10,171
+726
+8% +$117K 0.19% 39
2020
Q4
$1.49M Sell
9,445
-514
-5% -$75.9K 0.18% 41
2020
Q3
$1.48M Buy
9,959
+515
+5% +$76.2K 0.2% 37
2020
Q2
$1.33M Sell
9,444
-849
-8% -$124K 0.19% 36
2020
Q1
$1.35M Sell
10,293
-425
-4% -$60.3K 0.23% 41
2019
Q4
$1.56M Sell
10,718
-211
-2% -$28.6K 0.24% 44
2019
Q3
$1.41M Sell
10,929
-602
-5% -$79.3K 0.23% 43
2019
Q2
$1.61M Buy
11,531
+869
+8% +$120K 0.27% 40
2019
Q1
$1.49M Sell
10,662
-649
-6% -$86.9K 0.26% 38
2018
Q4
$1.46M Sell
11,311
-332
-3% -$46.3K 0.28% 38
2018
Q3
$1.61M Buy
11,643
+395
+4% +$52.5K 0.28% 37
2018
Q2
$1.36M Sell
11,248
-17
-0.2% -$2.12K 0.26% 36
2018
Q1
$1.44M Sell
11,265
-810
-7% -$109K 0.28% 33
2017
Q4
$1.69M Sell
12,075
-119
-1% -$16.6K 0.31% 30
2017
Q3
$1.58M Buy
12,194
+66
+0.5% +$8.75K 0.31% 30
2017
Q2
$1.6M Sell
12,128
-84
-0.7% -$10.7K 0.32% 30
2017
Q1
$1.52M Buy
12,212
+342
+3% +$40.9K 0.32% 30
2016
Q4
$1.37M Sell
11,870
-425
-3% -$49.1K 0.3% 27
2016
Q3
$1.45M Sell
12,295
-383
-3% -$46.5K 0.34% 28
2016
Q2
$1.54M Buy
12,678
+2,849
+29% +$324K 0.38% 27
2016
Q1
$1.06M Sell
9,829
-735
-7% -$76.1K 0.28% 29
2015
Q4
$1.08M Buy
10,564
+777
+8% +$78.1K 0.29% 29
2015
Q3
$914K Buy
9,787
+1,142
+13% +$110K 0.23% 33
2015
Q2
$843K Buy
8,645
+30
+0.3% +$3K 0.21% 31
2015
Q1
$867K Sell
8,615
-110
-1% -$11.2K 0.22% 30
2014
Q4
$912K Sell
8,725
-181
-2% -$19.1K 0.25% 29
2014
Q3
$875K Sell
8,906
-171
-2% -$17.7K 0.26% 35
2014
Q2
$892K Buy
9,077
+155
+2% +$15.7K 0.28% 31
2014
Q1
$876K Buy
8,922
+384
+4% +$35.6K 0.29% 30
2013
Q4
$839K Buy
8,538
+154
+2% +$14.2K 0.3% 28
2013
Q3
$824K Buy
8,384
+926
+12% +$83.1K 0.45% 25
2013
Q2
$733K Buy
+7,458
New +$633K 0.44% 24

Other funds holding JNJ

MCF Advisors's JNJ Position: Q2 2026 in Review

MCF Advisors increased its Johnson & Johnson (JNJ) stake by 3.8% in Q2 2026, buying an estimated $217K and bringing the position to 25,362 shares worth $6.44M. The position accounts for 0.23% of the portfolio, ranked #60.

MCF Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MCF Advisors held 25,362 shares of Johnson & Johnson worth $6.44M as of Q2 2026.
  • MCF Advisors bought 933 Johnson & Johnson shares in Q2 2026, an estimated $217K.
  • Johnson & Johnson made up 0.23% of MCF Advisors's portfolio in Q2 2026, its #60 holding.
  • MCF Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.